BioFactura
2004
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series B
LATEST DEAL TYPE
$6M
LATEST DEAL AMOUNT
12
INVESTORS
Description
Developer of a biomanufacturing platform designed for biodefense vaccines and biological drugs. The company's platform is a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical which include cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize patented multiplexed selection technology, enabling physicians to commercializes products to market with faster, lower cost at superior-quality.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
- 8435 Progress Drive
- Suite Z
- Frederick, MD 21701
- United States
+1 (301) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore BioFactura’s full profile, request a free trial.
BioFactura Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Corporate (Series B) | 29-Apr-2019 | $6M | 00.000 | Completed | Generating Revenue | |
| 8. Grant | 01-Jan-2018 | 00000 | 00.000 | Completed | Generating Revenue | |
| 7. Angel (individual) | 26-Apr-2016 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 6. Grant | 07-Apr-2016 | 0000 | 0000 | Completed | Generating Revenue | |
| 5. Accelerator/Incubator | 04-Sep-2015 | 0000 | Completed | Generating Revenue | ||
| 4. Grant | 15-Sep-2014 | 0000 | Completed | Generating Revenue | ||
| 3. Grant | 26-Jun-2012 | 00.000 | 0000 | Completed | Generating Revenue | |
| 2. Accelerator/Incubator | 31-Jan-2006 | $25K | $25K | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2006 | $3.07M | Completed | Generating Revenue |
BioFactura Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kymab | Venture Capital-Backed | Cambridge, United Kingdom | 000 | 00000 | 0000000000 0 | 00000 |
| 00000000 | Corporation | Austin, TX | 00 | 0000 | 00000000 | 0000 |
| 0000000 0000000000 | Formerly VC-backed | Cambridge, United Kingdom | 00 | 00000 | 00000000 | 00000 |
| 00000 000000000000 | Venture Capital-Backed | Boston, MA | 00 | 0000 | 00000000000 | 0000 |
| 00000 000000000000 | Venture Capital-Backed | Oxfordshire, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
BioFactura Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| University Of Vermont Health Network | Corporation | Minority | 000 0000 | 000000 0 | ||
| Wilson Sonsini Goodrich & Rosati | Corporation | Minority | 000 0000 | 000000 0 | ||
| Jeffrey Hausfeld | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Maryland Department of Commerce | Government | 000 0000 | 000000 0 | |||
| St. Louis Development | Lender/Debt Provider | Minority | 000 0000 | 000000 0 |
BioFactura Executive Team (4)
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »BioFactura Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Alex DeSeabra | BioFactura | Co-founder, Board Member & Consultant | 000 0000 | |
| Darryl Sampey Ph.D | BioFactura | Chief Executive Officer, President, Board Member, Chief Scientific Officer and Co-Founder | 000 0000 | |
| Jeffrey Hausfeld MD | BioFactura | Chief Medical Officer & Chairman | 000 0000 |
1 Former Board Member
You’re viewing 3 of 4 board members. Get the full list »